Amir Kalali, MD

Advisor

Dr. Amir Kalali is a globally recognized thought leader and innovator focused on the rapidly growing intersection between life sciences and technology. In his capacity as a neuroscientist, Dr. Kalali is: the Founding Chairman of the Executive Committee of the International Society for CNS Drug Development (ISCDD); Editor of the journal Innovations in Clinical Neuroscience; Founder and Co-Chair of the Scientific Program Committee of the CNS Summit; a founding member of the International Society for CNS Clinical Trials and Methodology (ISCTM); and a member of the Scientific Program Committee of the American College of Neuropsychopharmacology (ACNP). He was also the lead editor of the book Essential CNS Drug Development. In addition to his neuroscience pursuits, Dr. Kalali devotes a substantial portion of his time to topics related to the digitization of life sciences. In this domain, he serves as an advisor to Bracket, AiCure and the Center for Digital Transformation at the Paul Merage School of Business. Dr. Kalali is also a Professor of Psychiatry at University of California San Diego. Previously he was the Global Head of the Neuroscience Center of Excellence at QuintilesIMS where, among his other accomplishments, he was responsible for multiple successful drug development programs.